Over the past decades, observational studies have amply documented that the price of increasing life expectancy was an increasing burden of co-morbid conditions in ageing populations, in particular cardiovascular disease and dementia. These two ailments co-exist more frequently than expected on the basis of chance alone, and there are robust data indicating that atherosclerosis and cognitive impairment share common risk factors and pathophysiology. This body of evidence has led to the formulation of the concept of 'heart-brain connection'. 1 In the present issue of the journal, Schievink et al. 2 report data from the well-known Maastricht Aging Study (MAAS) pertaining to the heart-brain connection. In the MAAS, cognitively healthy participants were prospectively evaluated at enrolment and 6 and 12 years during follow-up. Participants were subjected to extensive cognitive function evaluations of verbal memory, executive function, and information processing speed, at baseline and during 12 years of follow-up. The analyses were stratified according to the presence of prevalent cardiovascular disease at enrolment and the development of incident cardiovascular disease during follow-up. There was a cross-sectional association between prevalent cardiovascular disease and cognitive impairment at enrolment. During follow-up, cognitive impairment was more frequent among patients who had developed cardiovascular disease. The associations were stronger among younger individuals, and the development of cognitive impairment was progressive and noted rather late over the course of the follow-up. The study has several notable methodological strengths including the robust cohort design, the careful assessment of multiple domains of cognitive function among a large cohort, and the longitudinal follow-up. The cohort design and the prospective careful, rigorous evaluation of cognition are particularly important to underscore. Indeed, while the association between cardiovascular disease and cognitive impairment has been previously reported, 1 the data from the MAAS strengthens our knowledge because of its prospective cohort design, as several previous studies were limited by cross-sectional or case-control methods. In a cohort, participants free of disease at baseline are followed longitudinally for the occurrence of events, which enables the ascertainment of causal relationships between a given risk factor and the outcome. The MAAS also included a painstaking evaluation of several cognition domains, a distinct advantage over the studies that relied on clinical diagnoses or insurance claims, inherently less precise. Taken collectively, the methodological strengths of the MAAS and the robustness of the causal inference derived from such epidemiological studies are critical to plan clinical interventions.
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The results of the MAAS along with observations from other studies raise interesting mechanistic points about the exact nexus between the heart and the brain ( Figure 1 ). Shared risk factors probably play a central role as demonstrated in other cohorts. Data from the Atherosclerosis Risk in Communities (ARIC) cohort indicate an association between midlife hypertension and later development of cognitive decline 3 or between diabetes and cognitive impairment. 4 In the Tromsø study, 5 diabetes, hypertension, and low physical activity were related to lower cognitive functioning. In several studies, the relationship to blood pressure is interestingly depicted as U-shaped, whereby cognitive impairment is associated with both high blood pressure (mediated by strokes and lacunar infarcts) and overly low blood pressure (mediated by low perfusion). 1 The accumulation of multiple risk factors in mid life appears to amplify the risk of cognitive decline conferred by each single risk factor. Further evidence of the shared risk factor hypothesis is provided by the recent temporal trends in cardiovascular disease and dementia. While both cardiovascular disease and dementia are becoming more prevalent as life expectancy increases, there is evidence that the incidence of both cardiovascular diseases and dementia has been declining in recent years. These encouraging findings have been reported in two different populations (the Framingham Heart Study and the Rochester Epidemiology Project, [6] [7] [8] [9] where concomitant declines in the clinical manifestations of cardiovascular disease and dementia have been noted. Because these findings are ecological and derived from populations of European ancestry, they must be interpreted with caution and must be replicated in different populations. However, their convergence adds more credence to the hypothesis of shared mechanistic pathways. One important question is which of the putative shared risk factors played the most important role in these trends. Certainly, trends in risk factor have not been homogeneous as diabetes and obesity have increased in established market economies 10 while trends in hypertension control and tobacco use have been generally more favourable. 11 The increasingly ubiquitous prescription of statin drugs is generally believed to have played a role in the decline in cardiovascular disease, but their impact on the prevention of dementia remains unresolved. 12 Taken collectively, these data support the notion that cardiovascular disease and cognitive impairment share causal pathways. The clinical implications of these findings are important as these results should change clinical practice. They reinforce the importance of aggressive management of cardiovascular disease risk factors because primary prevention of these risk factors and their control once they develop can also prevent dementia. Societal and behavioural factors are the cornerstone of prevention, and medical professionals play a key role in dissemination of their value to populations and in advocacy with industry and policy makers. To this end, a year ago, the European Guidelines on cardiovascular disease prevention in clinical practice were published as a result of the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Experts and representatives of 10 societies created this important roadmap for effective prevention of cardiovascular disease. 13 The realization that preventing cardiovascular disease can also prevent dementia or slow down the course of early stage cognitive impairment should galvanize our efforts. Given the limited treatment options for overt dementia and its devastating consequences, the roadmap of the Sixth Joint Task Force should be embraced as an opportunity to improve not only cardiovascular health but also cognitive health. Once cardiovascular events manifest clinically, cognitive function worsens ( Figure 1) . This is one of the key results of the MAAS. The putative link between cardiovascular events and cognitive impairment is multifold, including embolic stroke, low cardiac output, and possibly combination thereof. Delineating the respective responsibility of these clinical events over and above that of cardiovascular risk factors is challenging because of the aforementioned shared causal pathways. Doing so would require very large sample size and lengthy follow-up to enable extensive and complex adjustment. This was not carried out in the MAAS. This is an interesting mechanistic question, which should be studied while not hindering interventions today as there is a strong rationale for immediate action. For example, there is robust evidence that embolic strokes in atrial fibrillation have a deleterious impact on cognition. Evidence is equally robust that, despite ample clinical trial data documenting benefits in stroke prevention, anticoagulation is underutilized in atrial fibrillation, which arguably constitutes one of the largest implementation gaps in clinical medicine today.
14 Hence the determinants of underuse of anticoagulation must be urgently studied, understood, and addressed, while studying cognitive in addition to cardiovascular outcomes. Preventing or delaying the progression of cognitive decline in cardiovascular disease is particularly important as self-management of heart disease is at the crux of its effective treatment. Indeed, health literacy and self-efficacy are essential for adherence to medical therapies and dietary and physical activity recommendations. In heart failure for example, selfmanagement is the cornerstone of prevention of readmission but the prevalence of cognition impairment has been reported to be as high as 30% among patients living with heart failure. 1 As cognitive impairment can be concealed, particularly in its early phases, cardiovascular practitioners should assess cognitive function in their patients to guide their management plan. The heart-brain connection encourages us to reflect on multimorbidity in cardiovascular disease. Chronic disease epidemiology of ageing populations abundantly documents that cardiovascular disease does not occur in isolation, and the prevalence of multiple chronic conditions among patients living with heart disease is very high. 15 This observation underscores the limitations of disease-centric management strategies. While an exhaustive taxonomy of multimorbidity in cardiovascular disease is still work in progress, cognition and heart disease are probably congruent in their causation, and their prevention calls for congruent strategies. This is sufficient to act. The MAAS data encourage us to do so and we must now respond.
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